SCHEMBL6375097

SCHEMBL6375097

O=C(O)[C@@H]1C[C@@H](OCc2cccc3ccccc23)CN1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GRIK1 P39086 4/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ EPHX1 P07099 1/20 0.42
▸ SLC1A3 P43003 1/20 0.41
▸ SLC1A2 P43004 1/20 0.41
▸ SLC1A1 P43005 1/20 0.41
▸ GRM2 Q14416 1/20 0.40
▸ GRM3 Q14832 1/20 0.40
▸ GRIA2 P42262 2/20 0.40
▸ FFAR1 O14842 1/20 0.40
▸ AKR1B1 P15121 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PARP10 Q53GL7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6375085 1.00 GRIK1 (0.44) GRIK1CYP2D6TDP1EPHX1SLC1A3
SCHEMBL6375091 1.00 GRIK1 (0.44) GRIK1CYP2D6TDP1EPHX1SLC1A3
SCHEMBL25657697 0.82 FAAH (0.44) GRIK1
SCHEMBL25657696 0.82 FAAH (0.44) GRIK1
SCHEMBL25178685 0.82 EPHX2 (0.44) GRIK1GRIA2
SCHEMBL25185805 0.82 EPHX2 (0.44) GRIK1GRIA2
SCHEMBL13953141 0.81 MMP2 (0.38) TDP1MEN1KMT2A
SCHEMBL13893883 0.81 MMP2 (0.38) TDP1MEN1KMT2A
SCHEMBL8302932 0.80 MAPT (0.43) MEN1KMT2A
SCHEMBL8302927 0.80 MAPT (0.43) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003775-B1 HEPATITIS C INHIBITOR PEPTIDES BOEHRINGER INGELHEIM CA LTD (CA) 2005-03-16 — — EP disclosed
US-6767991-B1 PEPTIDES AND ANALOGS THEREOF; VIRAL PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH PEPTIDES AND RIBAVIRIN BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2004-07-27 — — US disclosed
Send feedback